Literature DB >> 33153875

Dosimetric impact of switching from AAA to Acuros dose-to-water and dose-to-medium for RapidArc plans of nasopharyngeal carcinomas.

R Sayah1, T Felefly2, L Zouein3, J El Barouky4, N Khater5, N Farah6, C Roukoz2, C El Khoury2, F Azoury2, D Nehme Nasr2, E Nasr2.   

Abstract

PURPOSE: This work aims to evaluate the dosimetric consequences of replacing the Anisotropic Analytical Algorithm (AAA) by Acuros XB (AXB), dose-to-water (Dw) or dose-to-medium (Dm), for RapidArc plans of nasopharyngeal carcinomas (NPC).
MATERIALS AND METHODS: Seventeen NPC plans created with AAA (v15.6) were recalculated with AXB (v15.6) Dw and Dm. The dose-volume parameters to the planning target volumes (PTV) and relevant organs at risk (OAR) were compared. The high dose PTV was divided into bone, air and tissue components and the comparison was performed for each of them.
RESULTS: AXB Dw revealed no significant differences in the PTVs compared to AAA. Lower values were observed to spinal cord, brainstem, oral cavity and parotids (0.5% to 2.3%), and higher values to cochleas (up to 5.4%) and mandible (up to 6.7%). AXB Dm predicted lower values than AAA for all PTVs and OARs (2.0% to 6.1%). For the bone PTV subvolume, AXB Dw and Dm predicted respectively higher (2.4%) and lower (2.2% to 3.4%) values. No significant differences were noted in air. AXB predicted lower values than AAA in soft tissues (0.4% to 1.6%). The largest difference was found to the mandible V60Gy parameter, with median differences of 6.7% for AXB Dw and -6.0% for AXB Dm.
CONCLUSION: Significant dose differences are expected when switching from AAA to AXB in NPC cases. The dose prescriptions and the tolerance limits for some OARs, especially those of high density, may need to be adjusted depending on the selected dose calculation algorithm and reporting mode.
Copyright © 2020 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Acuros XB; Algorithme Analytique Anisotrope; Anisotropic Analytical Algorithm; Carcinome du nasopharynx; Nasopharyngeal carcinoma

Mesh:

Substances:

Year:  2020        PMID: 33153875     DOI: 10.1016/j.canrad.2020.05.014

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  3 in total

1.  Radiobiological Comparison of Acuros External Beam and Anisotropic Analytical Algorithm on Esophageal Carcinoma Radiotherapy Treatment Plans.

Authors:  Lin Wang; Jianping Zhang; Miaoyun Huang; Benhua Xu; Xiaobo Li
Journal:  Dose Response       Date:  2022-07-08       Impact factor: 2.623

2.  Maintaining dosimetric quality when switching to a Monte Carlo dose engine for head and neck volumetric-modulated arc therapy planning.

Authors:  Vladimir Feygelman; Kujtim Latifi; Mark Bowers; Kevin Greco; Eduardo G Moros; Max Isacson; Agnes Angerud; Jimmy Caudell
Journal:  J Appl Clin Med Phys       Date:  2022-02-25       Impact factor: 2.243

3.  Influence of beamlet width on dynamic IMRT plan quality in nasopharyngeal carcinoma.

Authors:  Manya Wu; Jinhui Jin; Zhenghuan Li; Fantu Kong; Yadi He; Lijiang Liu; Wei Yang; Xiangying Xu
Journal:  PeerJ       Date:  2022-08-05       Impact factor: 3.061

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.